Ng Tit

All filings by Ng Tit on record concern China NT Pharma Group Co. Ltd. We count 18 filings; the first trade dates from 22 August 2017 and the latest from 21 February 2025.

In open-market terms, that means 15 purchases worth €46.0M on one side and 3 sales worth €9.5M on the other. No amount is published for 3 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.

Half of the purchases are above €9,686 and half below. Of 14 purchases, 13 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 13 purchases with a full 90-day history, the hit rate stands at 8% and the median 90-day move at -38.4%. This is a record of the past, not a forecast.

Most recently, on 25 February 2025, the filings show an open-market purchase worth €10.7M in China NT Pharma Group Co. Ltd. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.